- Home
- PRFX vs BENF Comparison
PRFX vs BENF Comparison
Compare PRFX & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- BENF
- Stock Information
- Founded
- PRFX 2007
- BENF 2003
- Country
- PRFX Israel
- BENF United States
- Employees
- PRFX N/A
- BENF N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- BENF Blank Checks
- Sector
- PRFX Health Care
- BENF Finance
- Exchange
- PRFX Nasdaq
- BENF Nasdaq
- Market Cap
- PRFX 2.9M
- BENF 2.6M
- IPO Year
- PRFX 2020
- BENF N/A
- Fundamental
- Price
- PRFX $1.40
- BENF $0.30
- Analyst Decision
- PRFX Hold
- BENF
- Analyst Count
- PRFX 1
- BENF 0
- Target Price
- PRFX N/A
- BENF N/A
- AVG Volume (30 Days)
- PRFX 326.0K
- BENF 507.8K
- Earning Date
- PRFX 08-14-2025
- BENF 08-13-2025
- Dividend Yield
- PRFX N/A
- BENF N/A
- EPS Growth
- PRFX N/A
- BENF N/A
- EPS
- PRFX N/A
- BENF N/A
- Revenue
- PRFX N/A
- BENF N/A
- Revenue This Year
- PRFX N/A
- BENF N/A
- Revenue Next Year
- PRFX N/A
- BENF N/A
- P/E Ratio
- PRFX N/A
- BENF N/A
- Revenue Growth
- PRFX N/A
- BENF N/A
- 52 Week Low
- PRFX $1.25
- BENF $0.22
- 52 Week High
- PRFX $16.63
- BENF $4.60
- Technical
- Relative Strength Index (RSI)
- PRFX 35.72
- BENF 50.67
- Support Level
- PRFX $1.25
- BENF $0.29
- Resistance Level
- PRFX $1.44
- BENF $0.33
- Average True Range (ATR)
- PRFX 0.10
- BENF 0.03
- MACD
- PRFX 0.01
- BENF 0.00
- Stochastic Oscillator
- PRFX 50.00
- BENF 26.79
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.